ストックスクリーナーアプリを入手
8.57
0.71%
0.06
前日終値:
$8.51
開ける：
$8.51
24時間の取引高:
764.47K
Relative Volume:
0.86
時価総額：
$640.02M
収益：
-
当期純損益:
$-27.03M
株価収益率:
-15.30
EPS:
-0.56
ネットキャッシュフロー:
$-23.97M
1週間 パフォーマンス:
-2.28%
1か月 パフォーマンス:
+19.03%
6か月 パフォーマンス:
+136.09%
1年 パフォーマンス:
-4.14%
1日の値動き範囲:
$8.34
$8.80
1週間の範囲:
$8.34
$9.24
52週間の値動き範囲:
$2.54
$9.55
Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile
名前
Corvus Pharmaceuticals Inc
セクター
電話
(650) 900-4520
住所
863 MITTEN ROAD, BURLINGAME, CA
CRVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRVS
Corvus Pharmaceuticals Inc
|
8.57 | 635.54M | 0 | -27.03M | -23.97M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.76 | 107.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
755.90 | 77.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.38 | 58.90B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.92 | 56.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
198.76 | 42.58B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-01-02 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-18 | 開始されました | Oppenheimer | Outperform |
| 2021-12-01 | 再開されました | Jefferies | Buy |
| 2021-05-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-02-10 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-05-29 | 開始されました | ROTH Capital | Buy |
| 2017-08-24 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2017-05-01 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2016-04-18 | 開始されました | Credit Suisse | Outperform |
| 2016-04-18 | 開始されました | Guggenheim | Buy |
すべてを表示
Corvus Pharmaceuticals Inc (CRVS) 最新ニュース
What risks investors should watch in Corvus Pharmaceuticals Inc. stockWeekly Trend Summary & Weekly Watchlist for Consistent Profits - newser.com
Will Corvus Pharmaceuticals Inc. stock reach Wall Street targetsPortfolio Growth Summary & Technical Buy Zone Confirmation - newser.com
Is Corvus Pharmaceuticals Inc. stock affected by interest rate hikes2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Is Corvus Pharmaceuticals Inc. stock supported by innovation pipeline2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
What valuation multiples suggest for Corvus Pharmaceuticals Inc. stockRecession Risk & AI Forecast Swing Trade Picks - newser.com
Corvus Pharmaceuticals Inc. stock momentum explainedWeekly Profit Report & Verified Swing Trading Watchlist - newser.com
Its Stock Has Paid Off Big Time For Corvus Pharmaceuticals Inc - Setenews
Corvus Pharmaceuticals Inc. recovery potential after sell offPortfolio Update Summary & Safe Capital Growth Tips - newser.com
Using RSI to spot recovery in Corvus Pharmaceuticals Inc.Earnings Growth Report & Long-Term Growth Portfolio Plans - newser.com
Combining price and volume data for Corvus Pharmaceuticals Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - newser.com
Is Corvus Pharmaceuticals Inc. forming a bottoming baseTrade Risk Summary & Fast Moving Stock Watchlists - newser.com
What drives Corvus Pharmaceuticals Inc stock priceEarnings Miss Alerts & Free Wealth Planning Blueprints - earlytimes.in
Is Corvus Pharmaceuticals Inc a good long term investmentEconomic Impact on Stocks & Double Digit Capital Growth - earlytimes.in
What machine learning models say about Corvus Pharmaceuticals Inc.Weekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com
How to build a dashboard for Corvus Pharmaceuticals Inc. stockJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
Is Corvus Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Should you wait for a breakout in Corvus Pharmaceuticals Inc.Index Update & Safe Entry Zone Tips - newser.com
Get in on Corvus Pharmaceuticals Inc’s (CRVS) buy-in window today! - setenews.com
Mizuho Securities Keeps Their Buy Rating on Corvus Pharmaceuticals (CRVS) - The Globe and Mail
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Q3 2025 Earnings Call Transcript - MSN
Why Corvus Pharmaceuticals Inc. stock could benefit from AI revolutionWeekly Gains Summary & Short-Term Swing Trade Alerts - newser.com
Corvus Pharmaceuticals: Moving Slowly Forward (NASDAQ:CRVS) - Seeking Alpha
What technical models suggest about Corvus Pharmaceuticals Inc.’s comebackWeekly Trend Recap & Consistent Profit Alerts - newser.com
Corvus Pharmaceuticals Reports Positive Q3 Earnings Call - MSN
HC Wainwright Has Positive Outlook for CRVS FY2025 Earnings - Defense World
Corvus Pharmaceuticals Inc (CRVS) 財務データ
収益
当期純利益
現金流量
EPS
1.38%
1.42%
大文字化:
|
ボリューム (24 時間):